Fig. 1.

Fig. 2.

Antibiotic susceptibility for C_ perfringens isolates (The E-test method, according to EUCAST 2017)_
| Isolate no. | Penicillins | Cephalo sporins | Carbapenems | Fluoroquinolones | Glycopeptide and lipo-glycopeptides | Macrolides, incosamides | Tetracyclines | Miscellaneous agents | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AML | P | PRL | XL | CRO | CTX | DOR | ETP | IMP | MEM | MXF | TEC | VA | E | DA | TE | C | M | RD | |
| 8554/M/17 (Patient 1) | MIC | 0.016 | 0.016 | 0.016 | 0.016 | 0.016 | 0.016 | 0.016 | 0.016 | 0.016 | 1.5 | 0.047 | 0.50 | 0.50 | 0.50 | 4 | 0.19 | 0.016 | 0.032 |
| S/R | S | S | S | S | S | S | S | S | S | R | S | S | R | S | R | S | S | S | |
| 8567/M/17 (Patient 2) | MIC | 0.016 | 0.016 | 0.016 | 0.016 | 0.016 | 0.016 | 0.016 | 0.016 | 0.016 | 2 | 0.047 | 0.50 | 0.50 | 0.50 | 4 | 0.125 | 0.016 | 0.032 |
| S/R | S | S | S | S | S | S | S | S | S | R | S | S | R | S | R | S | S | S | |